437 related articles for article (PubMed ID: 36759259)
41. Assessing causal relationship between circulating cytokines and age-related neurodegenerative diseases: a bidirectional two-sample Mendelian randomization analysis.
Yin Z; Chen J; Xia M; Zhang X; Li Y; Chen Z; Bao Q; Zhong W; Yao J; Wu K; Zhao L; Liang F
Sci Rep; 2023 Jul; 13(1):12325. PubMed ID: 37516812
[TBL] [Abstract][Full Text] [Related]
42. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
[TBL] [Abstract][Full Text] [Related]
43. Mitochondrial DNA damage and repair in neurodegenerative disorders.
Yang JL; Weissman L; Bohr VA; Mattson MP
DNA Repair (Amst); 2008 Jul; 7(7):1110-20. PubMed ID: 18463003
[TBL] [Abstract][Full Text] [Related]
44. Genetically Predicted Milk Intake and Risk of Neurodegenerative Diseases.
Zhang Z; Wang M; Yuan S; Larsson SC; Liu X
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445060
[TBL] [Abstract][Full Text] [Related]
45. The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
Chen Y; Cao B; Chen X; Ou R; Wei Q; Zhao B; Wu Y; Yuan L; Shang HF
Neurosci Lett; 2018 Nov; 686():205-210. PubMed ID: 30144538
[TBL] [Abstract][Full Text] [Related]
46. The effect of epigenetic aging on neurodegenerative diseases: a Mendelian randomization study.
Fan J; Liu Q; Liu X; Gong M; Leong II; Tsang Y; Xu X; Lei S; Duan L; Zhang Y; Liao M; Zhuang L
Front Endocrinol (Lausanne); 2024; 15():1372518. PubMed ID: 38800486
[TBL] [Abstract][Full Text] [Related]
47. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
48. Evidence for
Nalls MA; Blauwendraat C; Sargent L; Vitale D; Leonard H; Iwaki H; Song Y; Bandres-Ciga S; Menden K; Faghri F; Heutink P; Cookson MR; Singleton AB
Brain Commun; 2021; 3(2):fcab095. PubMed ID: 34693284
[TBL] [Abstract][Full Text] [Related]
49. Sleep/wake cycle alterations as a cause of neurodegenerative diseases: A Mendelian randomization study.
Cullell N; Cárcel-Márquez J; Gallego-Fábrega C; Muiño E; Llucià-Carol L; Lledós M; Amaut KEU; Krupinski J; Fernández-Cadenas I
Neurobiol Aging; 2021 Oct; 106():320.e1-320.e12. PubMed ID: 34130902
[TBL] [Abstract][Full Text] [Related]
50. The dawn of pirna research in various neuronal disorders.
Wakisaka KT; Imai Y
Front Biosci (Landmark Ed); 2019 Jun; 24(8):1440-1451. PubMed ID: 31136989
[TBL] [Abstract][Full Text] [Related]
51. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
La Cognata V; Morello G; Cavallaro S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
[TBL] [Abstract][Full Text] [Related]
52. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration.
Noori A; Mezlini AM; Hyman BT; Serrano-Pozo A; Das S
Neurobiol Dis; 2021 Feb; 149():105225. PubMed ID: 33347974
[TBL] [Abstract][Full Text] [Related]
53. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization.
Henry A; Gordillo-Marañón M; Finan C; Schmidt AF; Ferreira JP; Karra R; Sundström J; Lind L; Ärnlöv J; Zannad F; Mälarstig A; Hingorani AD; Lumbers RT;
Circulation; 2022 Apr; 145(16):1205-1217. PubMed ID: 35300523
[TBL] [Abstract][Full Text] [Related]
54. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
van Rheenen W; van der Spek RAA; Bakker MK; van Vugt JJFA; Hop PJ; Zwamborn RAJ; de Klein N; Westra HJ; Bakker OB; Deelen P; Shireby G; Hannon E; Moisse M; Baird D; Restuadi R; Dolzhenko E; Dekker AM; Gawor K; Westeneng HJ; Tazelaar GHP; van Eijk KR; Kooyman M; Byrne RP; Doherty M; Heverin M; Al Khleifat A; Iacoangeli A; Shatunov A; Ticozzi N; Cooper-Knock J; Smith BN; Gromicho M; Chandran S; Pal S; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Sendtner M; Meyer T; Başak N; van der Kooi AJ; Ratti A; Fogh I; Gellera C; Lauria G; Corti S; Cereda C; Sproviero D; D'Alfonso S; Sorarù G; Siciliano G; Filosto M; Padovani A; Chiò A; Calvo A; Moglia C; Brunetti M; Canosa A; Grassano M; Beghi E; Pupillo E; Logroscino G; Nefussy B; Osmanovic A; Nordin A; Lerner Y; Zabari M; Gotkine M; Baloh RH; Bell S; Vourc'h P; Corcia P; Couratier P; Millecamps S; Meininger V; Salachas F; Mora Pardina JS; Assialioui A; Rojas-García R; Dion PA; Ross JP; Ludolph AC; Weishaupt JH; Brenner D; Freischmidt A; Bensimon G; Brice A; Durr A; Payan CAM; Saker-Delye S; Wood NW; Topp S; Rademakers R; Tittmann L; Lieb W; Franke A; Ripke S; Braun A; Kraft J; Whiteman DC; Olsen CM; Uitterlinden AG; Hofman A; Rietschel M; Cichon S; Nöthen MM; Amouyel P; ; ; ; ; Traynor BJ; Singleton AB; Mitne Neto M; Cauchi RJ; Ophoff RA; Wiedau-Pazos M; Lomen-Hoerth C; van Deerlin VM; Grosskreutz J; Roediger A; Gaur N; Jörk A; Barthel T; Theele E; Ilse B; Stubendorff B; Witte OW; Steinbach R; Hübner CA; Graff C; Brylev L; Fominykh V; Demeshonok V; Ataulina A; Rogelj B; Koritnik B; Zidar J; Ravnik-Glavač M; Glavač D; Stević Z; Drory V; Povedano M; Blair IP; Kiernan MC; Benyamin B; Henderson RD; Furlong S; Mathers S; McCombe PA; Needham M; Ngo ST; Nicholson GA; Pamphlett R; Rowe DB; Steyn FJ; Williams KL; Mather KA; Sachdev PS; Henders AK; Wallace L; de Carvalho M; Pinto S; Petri S; Weber M; Rouleau GA; Silani V; Curtis CJ; Breen G; Glass JD; Brown RH; Landers JE; Shaw CE; Andersen PM; Groen EJN; van Es MA; Pasterkamp RJ; Fan D; Garton FC; McRae AF; Davey Smith G; Gaunt TR; Eberle MA; Mill J; McLaughlin RL; Hardiman O; Kenna KP; Wray NR; Tsai E; Runz H; Franke L; Al-Chalabi A; Van Damme P; van den Berg LH; Veldink JH
Nat Genet; 2021 Dec; 53(12):1636-1648. PubMed ID: 34873335
[TBL] [Abstract][Full Text] [Related]
55. Causal effects of serum sex hormone binding protein levels on the risk of amyotrophic lateral sclerosis: a mendelian randomization study.
Ou YN; Yang L; Wu BS; Tan L; Yu JT
Ann Transl Med; 2022 Oct; 10(19):1054. PubMed ID: 36330403
[TBL] [Abstract][Full Text] [Related]
56. Biomarkers for Managing Neurodegenerative Diseases.
Cheslow L; Snook AE; Waldman SA
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672416
[TBL] [Abstract][Full Text] [Related]
57. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
Gaggelli E; Kozlowski H; Valensin D; Valensin G
Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
[No Abstract] [Full Text] [Related]
58. [Conformationally altered proteins cause neurodegenerative diseases].
Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
[TBL] [Abstract][Full Text] [Related]
59. Dysregulation of glutathione homeostasis in neurodegenerative diseases.
Johnson WM; Wilson-Delfosse AL; Mieyal JJ
Nutrients; 2012 Oct; 4(10):1399-440. PubMed ID: 23201762
[TBL] [Abstract][Full Text] [Related]
60. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.
Salman MM; Al-Obaidi Z; Kitchen P; Loreto A; Bill RM; Wade-Martins R
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
